Reference
Laboratory analysis and QC glossary for research peptides
Published 2026-10-29 · updated 2026-10-29 · vendor-authored explanatory note
Short answer
This glossary defines the terms that appear on certificates of analysis and lot reports for research peptides, from the methods (HPLC, LC-MS, LAL) to the results (area percent, identity, net peptide content) and the handling vocabulary (lyophilization, hygroscopic, USP storage temperatures). Each definition links to the primary source it is based on.
Analytical methods
- High-performance liquid chromatography (HPLC)
- A separation technique that pumps a dissolved sample through a packed column so components elute at different times. For peptides it is the standard way to report chromatographic purity; it separates components but does not by itself prove which molecule a peak is. Source: USP Pharmacopeial Discussion Group · HPLC purity and area percent
- Reversed-phase HPLC (RP-HPLC)
- The HPLC mode most used to purify and analyze peptides, separating them by hydrophobicity on a non-polar stationary phase. Trifluoroacetic acid is commonly used in the mobile phase, which is why HPLC-purified peptides are often isolated as TFA salts (Cornish et al., 1999). Source: Cornish J et al. Trifluoroacetate
- Liquid chromatography-mass spectrometry (LC-MS)
- HPLC coupled to a mass spectrometer. The chromatography separates components and the mass spectrometer measures their mass-to-charge ratio, which is how a lot report confirms identity (the observed mass matches the expected molecular weight). Source: ICH Q6B · HPLC vs LC-MS
- MALDI-TOF mass spectrometry (MALDI-TOF)
- Matrix-assisted laser desorption/ionization with a time-of-flight analyzer. An alternative identity method to LC-MS that measures intact molecular mass without a chromatographic separation step. Source: ICH Q6B
- Mass-to-charge ratio (m/z)
- The quantity a mass spectrometer actually measures. Peptides often carry several charges, so one molecule can appear as multiple m/z peaks that must be deconvoluted back to a single molecular mass. Source: ICH Q6B
- Chromatogram
- The detector trace from an HPLC run: signal on the vertical axis, time on the horizontal axis. A credible purity claim is backed by the chromatogram itself, not just a number. Source: USP Pharmacopeial Discussion Group
- Retention time
- The time at which a component elutes from the column under a stated method. It depends on column, gradient, flow and temperature, so retention times are only comparable within the same method. Source: USP Pharmacopeial Discussion Group
- Specificity
- The ability of an analytical procedure to assess the analyte unequivocally in the presence of expected impurities, degradants or matrix components. A purity method without demonstrated specificity can hide co-eluting impurities. Source: ICH Q2(R2)
- Limit of detection and limit of quantitation (LOD / LOQ)
- LOD is the lowest amount of analyte a procedure can detect; LOQ is the lowest amount it can quantify with acceptable precision and accuracy. Impurities below the LOQ cannot be reported as numbers. Source: ICH Q2(R2)
- Method validation
- Documented evidence that an analytical procedure is fit for its intended purpose, covering characteristics such as specificity, accuracy, precision, range and robustness. Source: ICH Q2(R2)
Results and impurities
- Area percent
- Main-peak area divided by the total integrated peak area, expressed as a percentage. It is a relative measure of chromatographic purity at the detection wavelength, not a measure of how much peptide is in the vial. Source: USP Pharmacopeial Discussion Group · HPLC purity and area percent
- Purity (chromatographic)
- The share of detected material that is the target compound, usually reported by HPLC area percent. Research peptides are often reported above 95% by HPLC while the solid's net peptide content is lower because of counter-ions and water. Source: Bachem
- Net peptide content
- The fraction of a lyophilized solid's weight that is peptide, as opposed to counter-ions (acetate, TFA) and residual moisture. Bachem notes it is typically 70-90% even for high-purity material. Source: Bachem
- Identity
- Confirmation that the material is the stated molecule, typically by matching the observed mass (LC-MS or MALDI-TOF) to the theoretical mass of the sequence. Source: ICH Q6B
- Molecular weight and monoisotopic mass
- Molecular weight is the average mass using natural isotope abundance; monoisotopic mass uses the most abundant isotope of each element. PubChem lists both, and a mass-spec identity result should say which one it compares against. Source: PubChem documentation
- Counter-ion
- The ion paired with charged groups on a peptide in the solid salt form, most often trifluoroacetate or acetate. Counter-ions add weight, which is one reason net peptide content is below 100%. Source: Bachem
- TFA salt
- A peptide isolated with trifluoroacetate (PubChem CID 6422) as the counter-ion, a by-product of RP-HPLC purification. Cornish et al. (1999) reported residual TFA at 10^-8 to 10^-7 M reduced osteoblast proliferation in culture, so salt form matters for cell-based work. Source: Cornish J et al. Trifluoroacetate
- Acetate salt
- A peptide with acetate (from acetic acid, PubChem CID 176) as the counter-ion, usually produced by ion exchange after purification. Often specified when residual TFA could interfere with an assay. Source: PubChem CID 176
- Deamidation
- Chemical conversion of asparagine or glutamine side chains to acids, a common degradation pathway that shifts mass by about 1 Da and can show up as a new HPLC peak. Moisture and temperature accelerate it. Source: Manning MC et al. Stability of protein pharmaceuticals
- Oxidation
- Degradation of oxidation-prone residues, chiefly methionine, cysteine and tryptophan. Sigma-Aldrich recommends limiting air exposure (for example an inert-gas overlay) for sequences containing them. Source: Sigma-Aldrich (Merck)
- Aggregation
- Physical association of peptide or protein molecules into dimers or larger species. It is a physical (not chemical) instability and can be triggered by freeze-thaw stress, moisture or temperature excursions. Source: Manning MC et al. Stability of protein pharmaceuticals
Microbiology
- Endotoxin
- Lipopolysaccharide from the outer membrane of Gram-negative bacteria. Results are reported in endotoxin units (EU) against a reference standard. Source: FDA Guidance for Industry · Endotoxin testing (LAL)
- Limulus amebocyte lysate test (LAL)
- The compendial bacterial endotoxins test, using horseshoe-crab blood-cell lysate in gel-clot, turbidimetric or chromogenic formats. Recombinant factor C (rFC) reagents are a synthetic alternative that must be validated for the sample. Source: FDA Guidance for Industry
- Sterility test
- A culture-based test for viable microorganisms (USP <71>, harmonized through the PDG; 21 CFR 610.12 for licensed biologics). Sterility and endotoxin are different tests: a sterile sample can still contain endotoxin. Source: 21 CFR 610.12 · USP <71> sterility vs rapid methods
Documentation and quality systems
- Certificate of analysis (COA)
- A laboratory report of test results for a specific lot: methods, results, laboratory, report date and lot number. A COA is only as useful as its match to the lot in hand. Source: ICH Q2(R2) · Peptide COA checklist
- Lot
- A batch, or an identified portion of a batch, with uniform character and quality within specified limits (21 CFR 210.3). Test results apply to a lot, not to a product name. Source: 21 CFR 210.3
- Lot number
- The distinctive combination of letters, numbers or symbols from which the history of a batch or lot can be traced (21 CFR 210.3). It is the key that ties a vial label to its COA. Source: 21 CFR 210.3 · Verify a lot
- Re-test period
- The period during which a material is expected to remain within specification under defined storage conditions, after which it should be re-examined. ICH Q1A(R2) distinguishes it from the shelf life used for finished products. Source: ICH Q1A(R2)
- ISO/IEC 17025
- The international standard for the competence of testing and calibration laboratories. Accreditation is granted for a defined scope of methods, so check that the method on the COA is on the lab's scope. Source: ISO/IEC 17025 · ISO/IEC 17025 accreditation scope
- Scope of accreditation
- The published list of specific tests and methods an accredited lab is recognized to perform. Accreditation bodies that sign the ILAC MRA recognize each other's accreditations. Source: ILAC Mutual Recognition Arrangement and signatories
- CAS Registry Number
- A unique numeric identifier assigned by CAS to a chemical substance. Useful for unambiguous ordering and literature searches; it does not say anything about a specific lot's quality. Source: CAS Registry (CAS
- PubChem CID
- PubChem's compound identifier for a unique chemical structure, with computed properties such as formula and molecular weight. Different salt forms can have different CIDs. Source: PubChem documentation
- Safety Data Sheet (SDS)
- The standardized hazard document required under OSHA's Hazard Communication standard, covering hazards, handling, storage and exposure controls for a chemical. Source: OSHA 29 CFR 1910.1200
- Research use only (RUO)
- Labeling for materials sold for laboratory research. RUO materials are not intended for human or veterinary use, diagnostic use, or any use outside a controlled research setting. Source: OSHA 29 CFR 1910.1450
Handling and storage
- Lyophilization
- Freeze-drying: water is frozen and then removed by sublimation under vacuum, leaving a dry solid (the cake). The dry state slows most chemical degradation compared with solutions. Source: Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2) · Lyophilized material storage and handling
- Hygroscopic
- Readily absorbs moisture from air. Bachem notes most peptides are hygroscopic, and absorbed water reduces the peptide content of a weighed sample. Source: Bachem
- Desiccator
- A sealed container with a drying agent. Letting a cold vial warm to room temperature inside a desiccator before opening avoids condensation on the solid. Source: Bachem
- Freezer (USP definition)
- USP <659> defines a freezer as a place maintained thermostatically between -25 °C and -10 °C. Many peptide suppliers recommend -20 °C or colder for long-term storage of lyophilized material. Source: USP General Chapter <659> Packaging and Storage Requirements (Revision Bulletin)
- Refrigerator (USP definition)
- USP <659> defines refrigerated storage as a cold place maintained thermostatically between 2 °C and 8 °C. Source: USP General Chapter <659> Packaging and Storage Requirements (Revision Bulletin)
- Controlled room temperature
- USP <659>: thermostatically maintained 20-25 °C, with excursions between 15 °C and 30 °C allowed. Bachem notes lyophilized peptides generally tolerate room-temperature shipping. Source: USP General Chapter <659> Packaging and Storage Requirements (Revision Bulletin)
- Dry place
- USP <659>: a place that does not exceed 40% average relative humidity at 20 °C, or the equivalent water vapor pressure at other temperatures. Source: USP General Chapter <659> Packaging and Storage Requirements (Revision Bulletin)
- Freeze-thaw cycle
- One round of warming a frozen material and refreezing it. Repeated rounds add condensation and physical stress; Sigma-Aldrich recommends dividing material into single-use aliquots instead. Source: Sigma-Aldrich (Merck)
- Aliquot
- A measured portion split from a larger quantity so the rest stays sealed. Aliquoting limits repeated opening, moisture uptake and freeze-thaw exposure of the stock. Source: Sigma-Aldrich (Merck)
- Photostability
- Resistance to light-induced change. ICH Q1B confirmatory testing uses not less than 1.2 million lux hours of visible light plus 200 watt hours per square meter of near-UV, which is why amber or covered storage is the default. Source: ICH Q1B
- Inert gas overlay
- Replacing the air above a sample with dry nitrogen or argon before resealing. Recommended for sequences with oxidation-prone residues (Cys, Met, Trp). Source: Sigma-Aldrich (Merck)
How to use this glossary
Terms are grouped by where you meet them on a report. Every entry has a stable link (for example /glossary#area-percent) so lab notebooks, SOPs and other sites can cite a single definition.
Two distinctions cause most misreadings of a COA: chromatographic purity is not the same as net peptide content, and a purity result does not prove identity. The entries for area percent, net peptide content and identity explain why.
Related on Vitality Chems
- Peptide COA checklist — apply these terms to a real report.
- Lyophilized material storage and handling — temperature, light and moisture in practice.
- Verify a lot — look up a published Vitality Chems lot report.
- HPLC vs LC-MS — what each method proves.
Frequently asked
Is HPLC purity the same as the amount of peptide in a vial?
No. HPLC area percent compares the main peak with other detected peaks. The solid also contains counter-ions and water, so net peptide content is typically lower (Bachem cites 70-90%).
What is the difference between a TFA salt and an acetate salt?
They differ in the counter-ion paired with the peptide. TFA comes from HPLC purification; acetate is usually introduced by ion exchange when residual TFA could interfere with cell-based assays.
What does a lot number prove?
Nothing on its own. It is the link between a vial label and the test record for that batch. Match it against the report or look it up on the supplier's lot verification page.
References
- USP Pharmacopeial Discussion Group: harmonized general methods (chromatography, endotoxins, sterility)Primary source for one or more definitions below.
- Cornish J et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol. 1999;277(5):E779-83. PMID 10567002Primary source for one or more definitions below.
- ICH Q6B, Specifications for Biotechnological/Biological ProductsPrimary source for one or more definitions below.
- ICH Q2(R2), Validation of Analytical ProceduresPrimary source for one or more definitions below.
- Bachem: Care and Handling of Peptides (net peptide content)Primary source for one or more definitions below.
- PubChem documentation: compounds, substances and CIDsPrimary source for one or more definitions below.
- PubChem CID 176: Acetic acidPrimary source for one or more definitions below.
- Manning MC et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-75. PMID 20143256Primary source for one or more definitions below.
- Sigma-Aldrich (Merck): Handling and Storage Guidelines for Peptides and ProteinsPrimary source for one or more definitions below.
- FDA Guidance for Industry: Pyrogen and Endotoxins Testing, Questions and AnswersPrimary source for one or more definitions below.
- 21 CFR 610.12, SterilityPrimary source for one or more definitions below.
- 21 CFR 210.3, Definitions (batch, lot, lot number)Primary source for one or more definitions below.
- ICH Q1A(R2), Stability Testing of New Drug Substances and ProductsPrimary source for one or more definitions below.
- ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratoriesPrimary source for one or more definitions below.
- ILAC Mutual Recognition Arrangement and signatoriesPrimary source for one or more definitions below.
- CAS Registry (CAS, a division of the American Chemical Society)Primary source for one or more definitions below.
- OSHA 29 CFR 1910.1200, Hazard Communication (Safety Data Sheets)Primary source for one or more definitions below.
- OSHA 29 CFR 1910.1450, Occupational exposure to hazardous chemicals in laboratoriesPrimary source for one or more definitions below.
- Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. PMID 10967427Primary source for one or more definitions below.
- Bachem: Handling and Storage Guidelines for PeptidesPrimary source for one or more definitions below.
- USP General Chapter <659> Packaging and Storage Requirements (Revision Bulletin)Primary source for one or more definitions below.
- ICH Q1B, Photostability Testing of New Drug Substances and ProductsPrimary source for one or more definitions below.
